TY - JOUR
T1 - Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome
AU - Zarate, Yuri A.
AU - Smith-Hicks, Constance L.
AU - Greene, Carol
AU - Abbott, Mary Alice
AU - Siu, Victoria M.
AU - Calhoun, Amy R.U.L.
AU - Pandya, Arti
AU - Li, Chumei
AU - Sellars, Elizabeth A.
AU - Kaylor, Julie
AU - Bosanko, Katherine
AU - Kalsner, Louisa
AU - Basinger, Alice
AU - Slavotinek, Anne M.
AU - Perry, Hazel
AU - Saenz, Margarita
AU - Szybowska, Marta
AU - Wilson, Louise C.
AU - Kumar, Ajith
AU - Brain, Caroline
AU - Balasubramanian, Meena
AU - Dubbs, Holly
AU - Ortiz-Gonzalez, Xilma R.
AU - Zackai, Elaine
AU - Stein, Quinn
AU - Powell, Cynthia M.
AU - Schrier Vergano, Samantha
AU - Britt, Allison
AU - Sun, Angela
AU - Smith, Wendy
AU - Bebin, E. Martina
AU - Picker, Jonathan
AU - Kirby, Amelia
AU - Pinz, Hailey
AU - Bombei, Hannah
AU - Mahida, Sonal
AU - Cohen, Julie S.
AU - Fatemi, Ali
AU - Vernon, Hilary J.
AU - McClellan, Rebecca
AU - Fleming, Leah R.
AU - Knyszek, Brittney
AU - Steinraths, Michelle
AU - Velasco Gonzalez, Cruz
AU - Beck, Anita E.
AU - Golden-Grant, Katie L.
AU - Egense, Alena
AU - Parikh, Aditi
AU - Raimondi, Chantalle
AU - Angle, Brad
AU - Allen, William
AU - Schott, Suzanna
AU - Algrabli, Adi
AU - Robin, Nathaniel H.
AU - Ray, Joseph W.
AU - Everman, David B.
AU - Gambello, Michael J.
AU - Chung, Wendy K.
N1 - Funding Information:
The authors are grateful to all participating families. Clinicians seeking further information or advice on SAS can consult the dedicated website (www.satb2gene.com) or contact the corresponding author. WK Chung received support from the Simons Foundation and the JPB Foundation.
Publisher Copyright:
© 2018 Wiley Periodicals, Inc.
PY - 2018/4
Y1 - 2018/4
N2 - SATB2-associated syndrome (SAS) is an autosomal dominant disorder characterized by significant neurodevelopmental disabilities with limited to absent speech, behavioral issues, and craniofacial anomalies. Previous studies have largely been restricted to case reports and small series without in-depth phenotypic characterization or genotype-phenotype correlations. Seventy two study participants were identified as part of the SAS clinical registry. Individuals with a molecularly confirmed diagnosis of SAS were referred after clinical diagnostic testing. In this series we present the most comprehensive phenotypic and genotypic characterization of SAS to date, including prevalence of each clinical feature, neurodevelopmental milestones, and when available, patient management. We confirm that the most distinctive features are neurodevelopmental delay with invariably severely limited speech, abnormalities of the palate (cleft or high-arched), dental anomalies (crowding, macrodontia, abnormal shape), and behavioral issues with or without bone or brain anomalies. This comprehensive clinical characterization will help clinicians with the diagnosis, counseling and management of SAS and help provide families with anticipatory guidance.
AB - SATB2-associated syndrome (SAS) is an autosomal dominant disorder characterized by significant neurodevelopmental disabilities with limited to absent speech, behavioral issues, and craniofacial anomalies. Previous studies have largely been restricted to case reports and small series without in-depth phenotypic characterization or genotype-phenotype correlations. Seventy two study participants were identified as part of the SAS clinical registry. Individuals with a molecularly confirmed diagnosis of SAS were referred after clinical diagnostic testing. In this series we present the most comprehensive phenotypic and genotypic characterization of SAS to date, including prevalence of each clinical feature, neurodevelopmental milestones, and when available, patient management. We confirm that the most distinctive features are neurodevelopmental delay with invariably severely limited speech, abnormalities of the palate (cleft or high-arched), dental anomalies (crowding, macrodontia, abnormal shape), and behavioral issues with or without bone or brain anomalies. This comprehensive clinical characterization will help clinicians with the diagnosis, counseling and management of SAS and help provide families with anticipatory guidance.
KW - 2q33.1
KW - SATB
KW - SATB2-associated syndrome
KW - facial recognition technology
KW - genotype–phenotype correlation
KW - natural history
UR - http://www.scopus.com/inward/record.url?scp=85041920931&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041920931&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.38630
DO - 10.1002/ajmg.a.38630
M3 - Article
C2 - 29436146
AN - SCOPUS:85041920931
SN - 1552-4825
VL - 176
SP - 925
EP - 935
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 4
ER -